Avinash Aujayeb
Impact in
- Oncology top 1%
- Global Cancer Incidence and Screening
- COVID-19 and healthcare impacts
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Pleural and Pulmonary Diseases 55
- Occupational and environmental lung diseases 13
- Pneumothorax, Barotrauma, Emphysema 12
-
- COVID-19 Clinical Research Studies 29
- Co-authors
- Karl A. Jackson (17 shared papers)Nina Wiedemann (2 shared papers)Jannis Born (2 shared papers)Julie Goulet (1 shared paper)Karsten Borgwardt (1 shared paper)Bastian Rieck (1 shared paper)Michael Moor (1 shared paper)Wendy Funston (1 shared paper)
- Journals
- The Lancet (15 papers)The Lancet Infectious Diseases (8 papers)The Lancet Public Health (7 papers)EClinicalMedicine (5 papers)The Lancet Oncology (4 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Avinash Aujayeb
192 papers receiving 17.9k citations
Avinash Aujayeb's Hit Papers
Peers
Comparison fields: 5 of 189
- Oncology 2.5k
- Infectious Diseases 2k
- Epidemiology 1.9k
- Health, Toxicology and Mutagenesis 809
- Health Information Management 491
Countries citing papers authored by Avinash Aujayeb
This map shows the geographic impact of Avinash Aujayeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avinash Aujayeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avinash Aujayeb more than expected).
Fields of papers citing papers by Avinash Aujayeb
This network shows the impact of papers produced by Avinash Aujayeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avinash Aujayeb. The network helps show where Avinash Aujayeb may publish in the future.
Co-authors
The 25 scholars most cited alongside Avinash Aujayeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 3041 |
| 2 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1712 |
| 3 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1679 |
| 4 | Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Hit paper breakdown → | 2021 | 1461 |
| 5 | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1152 |
| 6 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 948 |
| 7 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 702 |
| 8 | The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 687 |
| 9 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 675 |
| 10 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 657 |
| 11 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 12 | Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 346 |
| 13 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 318 |
| 14 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 15 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 16 | 2020 | 227 | |
| 17 | 2021 | 218 | |
| 18 | Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 215 |
| 19 | 2021 | 213 | |
| 20 | 2021 | 200 |
About Avinash Aujayeb
Avinash Aujayeb is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Oncology, Internal Medicine and Neurology, having authored 233 papers that have together received 18.5k indexed citations. Recurring topics across this work include Pleural and Pulmonary Diseases (55 papers), COVID-19 Clinical Research Studies (29 papers), COVID-19 and healthcare impacts (19 papers), Occupational and environmental lung diseases (13 papers), Pneumothorax, Barotrauma, Emphysema (12 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Insurance, Mortality, Demography, Risk Management (8 papers) and Liver Disease and Transplantation (6 papers). The work is most often cited by research in Oncology (2.5k citations), Infectious Diseases (2k citations), Epidemiology (1.9k citations), Health, Toxicology and Mutagenesis (809 citations) and Health Information Management (491 citations). Avinash Aujayeb has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Karl A. Jackson, Nina Wiedemann, Jannis Born, Julie Goulet, Karsten Borgwardt, Bastian Rieck, Michael Moor, Wendy Funston, Philippe J. Astoul and David D. J. Cooper. Their work appears in journals such as The Lancet, The Lancet Infectious Diseases, The Lancet Public Health, EClinicalMedicine and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.